Edap Tms (NASDAQ:EDAP) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Edap Tms (NASDAQ:EDAP) in a research note issued to investors on Saturday. The brokerage issued a hold rating on the medical equipment provider’s stock.

Other equities research analysts have also issued reports about the company. Piper Sandler cut their price objective on Edap Tms from $5.00 to $4.50 and set an “overweight” rating on the stock in a research report on Friday, March 28th. HC Wainwright reissued a “buy” rating and set a $19.00 price objective on shares of Edap Tms in a research report on Friday, March 28th. Finally, Jefferies Financial Group restated a “hold” rating and issued a $2.00 price objective (down from $8.00) on shares of Edap Tms in a report on Friday.

Edap Tms Trading Down 9.9 %

Shares of EDAP opened at $1.45 on Friday. The stock has a market capitalization of $53.80 million, a P/E ratio of -2.23 and a beta of 0.12. Edap Tms has a twelve month low of $1.40 and a twelve month high of $8.50. The company has a quick ratio of 1.46, a current ratio of 2.18 and a debt-to-equity ratio of 0.08. The firm has a fifty day simple moving average of $2.37 and a two-hundred day simple moving average of $2.44.

Edap Tms (NASDAQ:EDAP) last posted its earnings results on Thursday, March 27th. The medical equipment provider reported ($0.05) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.06. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. The company had revenue of $22.69 million during the quarter, compared to analyst estimates of $20.83 million. On average, research analysts anticipate that Edap Tms will post -0.6 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the company. BNP Paribas Financial Markets raised its holdings in Edap Tms by 23.7% in the third quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock worth $59,000 after purchasing an additional 4,400 shares in the last quarter. Orion Capital Management LLC grew its position in shares of Edap Tms by 10.4% in the 3rd quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock worth $178,000 after buying an additional 6,600 shares during the period. Illumine Investment Management LLC bought a new position in shares of Edap Tms in the 4th quarter worth about $50,000. Rock Springs Capital Management LP lifted its position in Edap Tms by 1.5% during the 4th quarter. Rock Springs Capital Management LP now owns 1,591,800 shares of the medical equipment provider’s stock valued at $3,518,000 after acquiring an additional 23,800 shares during the period. Finally, Millennium Management LLC lifted its position in Edap Tms by 218.5% during the 4th quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock valued at $108,000 after acquiring an additional 33,558 shares during the period. Hedge funds and other institutional investors own 62.74% of the company’s stock.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.